Two for good measure: six versus eight cycles of carboplatin and paclitaxel as adjuvant treatment for epithelial ovarian cancer.

Don S Dizon; Sherry Weitzen; Adam Rojan; Joanna Schwartz; Jane Miller; Paul Disilvestro; Mary E Gordinier; Richard Moore; Trevor Tejada-Berges; Leslie Pires

doi:10.1016/j.ygyno.2005.10.031

Two for good measure: six versus eight cycles of carboplatin and paclitaxel as adjuvant treatment for epithelial ovarian cancer.

Identifier:nobleid.org/w1/20260515/4083DBB0

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/4083DBB0.svg?ark=w1%2F20260515%2F4083DBB0)](https://nobleid.org/work/w1/20260515/4083DBB0)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Two for good measure: six versus eight cycles of carboplatin and paclitaxel as adjuvant treatment for epithelial ovarian cancer.

Identifier:nobleid.org/w1/20260515/4083DBB0

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/4083DBB0.svg?ark=w1%2F20260515%2F4083DBB0)](https://nobleid.org/work/w1/20260515/4083DBB0)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work